Touyun Biotech Group Limited (1332.HK)

HKD 0.18

(-7.22%)

Operating Income Summary of Touyun Biotech Group Limited

Touyun Biotech Group Limited's latest annual operating income in 2023 was -90.31 Million HKD , down -240.24% from previous year.
Touyun Biotech Group Limited's latest quarterly operating income in 2024 Q2 was -36.36 Million HKD , down 0.0% from previous quarter.
Touyun Biotech Group Limited reported an annual operating income of -26.54 Million HKD in 2022, up 24.81% from previous year.
Touyun Biotech Group Limited reported an annual operating income of -35.3 Million HKD in 2021, up 51.75% from previous year.
Touyun Biotech Group Limited reported a quarterly operating income of -54.49 Million HKD for 2023 Q4, down 0.0% from previous quarter.
Touyun Biotech Group Limited reported a quarterly operating income of -35.82 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Touyun Biotech Group Limited (2023 - 2011)

Historical Annual Operating Income of Touyun Biotech Group Limited (2023 - 2011)

Year	Operating Income	Operating Income Growth
2023	-90.31 Million HKD	-240.24%
2022	-26.54 Million HKD	24.81%
2021	-35.3 Million HKD	51.75%
2020	-73.17 Million HKD	40.42%
2019	-122.81 Million HKD	16.53%
2018	-147.13 Million HKD	21.18%
2017	-186.66 Million HKD	71.07%
2016	-645.15 Million HKD	-387.78%
2015	-132.26 Million HKD	-1219.08%
2014	11.81 Million HKD	-21.32%
2013	15.02 Million HKD	-36.76%
2012	23.75 Million HKD	-45.0%
2011	43.18 Million HKD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-36.36 Million HKD	0.0%
2023 Q4	-54.49 Million HKD	0.0%
2023 Q2	-35.82 Million HKD	0.0%
2023 FY	-90.31 Million HKD	-240.24%
2022 Q4	-25.44 Million HKD	0.0%
2022 Q2	-17.02 Million HKD	0.0%
2022 FY	-26.54 Million HKD	24.81%
2021 FY	-35.3 Million HKD	51.75%
2021 Q4	-12.62 Million HKD	0.0%
2021 Q2	-18.55 Million HKD	0.0%
2020 FY	-73.17 Million HKD	40.42%
2020 Q2	-34.12 Million HKD	0.0%
2020 Q4	-27.01 Million HKD	0.0%
2019 Q4	-14.24 Million HKD	0.0%
2019 FY	-122.81 Million HKD	16.53%
2019 Q2	-21.99 Million HKD	0.0%
2018 Q4	-67.52 Million HKD	0.0%
2018 Q2	-79.16 Million HKD	0.0%
2018 FY	-147.13 Million HKD	21.18%
2017 Q2	-100.06 Million HKD	0.0%
2017 Q4	-34.55 Million HKD	0.0%
2017 FY	-186.66 Million HKD	71.07%
2016 FY	-645.15 Million HKD	-387.78%
2016 Q4	- HKD	0.0%
2016 Q2	-231.73 Million HKD	0.0%
2015 FY	-132.26 Million HKD	-1219.08%
2015 Q4	-54.39 Million HKD	0.0%
2015 Q2	-47.61 Million HKD	0.0%
2014 Q4	7.7 Million HKD	0.0%
2014 Q2	4.05 Million HKD	0.0%
2014 FY	11.81 Million HKD	-21.32%
2013 FY	15.02 Million HKD	-36.76%
2013 Q4	6.83 Million HKD	0.0%
2013 Q2	9.86 Million HKD	0.0%
2012 FY	23.75 Million HKD	-45.0%
2012 Q2	- HKD	0.0%
2012 Q4	- HKD	0.0%
2011 FY	43.18 Million HKD	0.0%

Peer Operating Income Comparison of Touyun Biotech Group Limited

Name	Operating Income	Operating Income Difference
Starlite Holdings Limited	26.3 Million HKD	443.301%
Litu Holdings Limited	-79.9 Million HKD	-13.03%
Champion Alliance International Holdings Limited	16.06 Million HKD	662.085%
Huaxi Holdings Company Limited	-42.85 Million HKD	-110.75%